Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS Supported ResourcesMIMS news
Ezetimibe supply update
Availability issues have been reported for the lipid-lowering...
Pharmacists across England to initiate oral contraceptives
Pharmacy Contraception Service (PCS) could allow almost...
MIMS dermatology supplement available online
Read the latest digital MIMS+ supplement for free now.
Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA
A National Patient Safety Alert (NatPSA) has been issued...
Alternate-day iron dosing in women 'effective and better tolerated'
In iron-depleted women, alternate-day iron supplementation...
New resource for ADHD prescribing
MIMS tool highlights available prescribing options.
NICE recommends broader use for second SGLT2 inhibitor in chronic kidney disease
Empagliflozin (Jardiance) is set to be available for...
NICE highlights effectiveness of CBT for menopausal symptoms
The risks and benefits of HRT are also reassessed in...
GP antibiotic prescribing in spotlight as resistant infections rise
The latest Government figures show that antibiotic...
Dual GIP/GLP-1 agonist approved for weight loss
Mounjaro (tirzepatide) helps regulate appetite, making...
NICE recommends 'life changing' technology for people with type I diabetes
'Artificial pancreas' could be offered to more than...
Hormone treatment approved for breast cancer prevention
Anastrozole is now licensed to prevent breast cancer...
Isotretinoin treatment for acne patients under 18 must be approved by two prescribers, MHRA rules
New measures have been introduced to strengthen the...
Enrich your knowledge and network with your peers in primary care
The deadline to register for FREE to MIMS Learning...
Drug shortages peak adversely affecting GPs and patients
Medicines shortages in Britain have reached an all-time...
New treatment for advanced Parkinson's disease recommended by NICE
Foslevodopa–foscarbidopa (Produodopa) has been endorsed...
Smoking cessation drug returns after long absence
GSK has announced that Zyban (bupropion) has returned...
New oral contraceptive offers extended missed-pill window
Slynd (drospirenone) is a progestogen-only contraceptive...
IBS symptoms improved by amitriptyline, study shows
Low-dose amitriptyline was significantly more effective...
Second oral CGRP antagonist offers further migraine prevention option
Atogepant (Aquipta) can be prescribed for the prophylaxis...